NIH Locks Doors for Secret Science Grant Reviews in April
Published Date: 3/11/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2025 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for health and science projects. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Confidentiality protections for applications
The meetings will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (including patentable material), and personal information tied to grant applications. This keeps applicants' proprietary and private information from public disclosure during the review process.
Closed virtual grant review meetings
The NIH Center for Scientific Review will hold multiple virtual, closed meetings to review and evaluate grant applications on April 7-9; April 8-9; April 14-15; April 17-18; April 21-23; April 22-23; April 24-25; April 28-29; and May 1-2, 2025. Each meeting's agenda is to review and evaluate grant applications, and the meetings are closed to the public.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22871, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for eye disease, neuronal injury, infectious diseases, and related projects. No public access is allowed to protect private info and trade secrets, but these reviews help decide who gets research money.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
2026-22111, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a virtual meeting on June 4, 2027, to share updates and review grant applications and staff performance. The first half is open to the public, while the second half is private to protect personal privacy. This meeting affects researchers and staff involved with NICHD grants and projects, with no direct cost changes announced.
Previous / Next Documents
Previous: 2025-03841, Combined Notice of Filings
The Federal Energy Regulatory Commission got a bunch of filings from natural gas pipeline companies about rate changes and updates starting March and April 2025. These changes could affect how much customers pay for fuel and pipeline services. If you want to say something, you’ve got until March 12, 2025, at 5 p.m. ET to comment!
Next: 2025-03845, Tiered Pharmacy Copayments for Medications; Calendar Year 2025 Update
Starting January 1, 2025, the VA is updating its list of Tier 1 medications, which means veterans will see changes in their copayments for certain common drugs like aspirin and cholesterol meds. These updates help keep costs fair and clear for veterans getting outpatient prescriptions. The new list stays active through the whole year, so veterans can plan their healthcare spending with confidence.